Literature DB >> 31806716

SABINA: global programme to evaluate prescriptions and clinical outcomes related to short-acting β2-agonist use in asthma.

Claudia S Cabrera1,2,3, Cassandra Nan4,3, Niklas Lindarck5, Maarten J H I Beekman6, Sofie Arnetorp1, Ralf J P van der Valk7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31806716     DOI： 10.1183/13993003.01858-2019

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  11 in total

1.  Short-acting β2-agonist prescriptions are associated with poor clinical outcomes of asthma: the multi-country, cross-sectional SABINA III study.

Authors:  Eric D Bateman; David B Price; Hao-Chien Wang; Adel Khattab; Patricia Schonffeldt; Angelina Catanzariti; Ralf J P van der Valk; Maarten J H I Beekman
Journal:  Eur Respir J       Date:  2022-05-05       Impact factor: 33.795

2.  Over-prescription of short-acting β2-agonists and asthma management in the Gulf region: a multicountry observational study.

Authors:  Ashraf Alzaabi; Nasser Al Busaidi; Rohit Pradhan; Fathelrahman Shandy; Naseem Ibrahim; Moulham Ashtar; Khaled Khudadah; Khaled Hegazy; Mohamed Samir; Mohamed Negm; Hisham Farouk; Arwa Al Khalidi; Maarten Beekman
Journal:  Asthma Res Pract       Date:  2022-07-07

3.  Short-acting β2-agonist prescription patterns in patients with asthma in Turkey: results from SABINA III.

Authors:  Arzu Yorgancıoğlu; Kurtuluş Aksu; Sibel Atış Naycı; Dane Ediger; Dilşad Mungan; Umut Gül; Maarten J H I Beekman
Journal:  BMC Pulm Med       Date:  2022-06-02       Impact factor: 3.320

4.  SABA Overuse in Russia - Burden and Possible Causes: An Analysis of the Russian Population in the SABINA III (SABA use IN Asthma) Study.

Authors:  Sergey Avdeev; Nikolay Voznesenskiy; Marina Boldina; Galina Ignatova; Natalya Kostina; Amirzhan Kulbaisov; Igor Leshchenko; Maarten J H I Beekman
Journal:  J Asthma Allergy       Date:  2022-03-24

5.  The carbon footprint of respiratory treatments in Europe and Canada: an observational study from the CARBON programme.

Authors:  Christer Janson; Ekaterina Maslova; Alexander Wilkinson; Erika Penz; Alberto Papi; Nigel Budgen; Claus F Vogelmeier; Maciej Kupczyk; John Bell; Andrew Menzies-Gow
Journal:  Eur Respir J       Date:  2022-08-10       Impact factor: 33.795

6.  Short-acting beta-2 agonist prescription patterns and clinical outcomes in Chinese patients with asthma: an observational study in mainland China for the SABINA programme.

Authors:  Wuping Bao; Yingying Zhang; Jingqing Hang; Yubiao Guo; Wei Tang; Chunmei Yun; Jingmin Deng; Meiling Jin; Kefang Lai; Huapeng Yu; Maarten Beekman; Xin Zhou; Min Zhang
Journal:  Ther Adv Respir Dis       Date:  2022 Jan-Dec       Impact factor: 5.158

7.  A Cross-Sectional Study on Prescription Patterns of Short-Acting β2-Agonists in Patients with Asthma: Results from the SABINA III Colombia Cohort.

Authors:  John Carlos Pedrozo-Pupo; Manuel Conrado Pacheco Gallego; Iván de Jesús Baños Álvarez; Rodolfo Antonio Jaller Raad; Andrea Carolina Caballero Pinilla; Humberto Reynales Londoño; Laura Bernal Villada; Maarten Beekman
Journal:  J Asthma Allergy       Date:  2022-08-26

8.  Short-acting β2-agonist prescription patterns for asthma management in the SABINA III primary care cohort.

Authors:  David Price; Kerry Hancock; Joseph Doan; Sri Wahyu Taher; Chakaya J Muhwa; Hisham Farouk; Maarten J H I Beekman
Journal:  NPJ Prim Care Respir Med       Date:  2022-09-29       Impact factor: 3.289

9.  Manifesto on the overuse of SABA in the management of asthma: new approaches and new strategies.

Authors:  Giorgio Walter Canonica; Pierluigi Paggiaro; Francesco Blasi; Antonino Musarra; Luca Richeldi; Andrea Rossi; Alberto Papi
Journal:  Ther Adv Respir Dis       Date:  2021 Jan-Dec       Impact factor: 4.031

10.  Characteristics of Reliever Inhaler Users and Asthma Control: A Cross-Sectional Multicenter Study in Portuguese Community Pharmacies.

Authors:  Mariana Romão; Ana Rita Godinho; Pedro M Teixeira; Zilda Mendes; Filipa Bernardo; António Teixeira Rodrigues; Jaime Correia de Sousa
Journal:  J Asthma Allergy       Date:  2021-07-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.